Update on Interim Dividend Timetable

RNS Number : 8493R

Alliance Pharma PLC

09 November 2021

 

For immediate release

9 November 2021

ALLIANCE PHARMA PLC

("Alliance" or the "Group")

Update on interim dividend timetable

In the Group's interim results for the six months ended 30 June 2021 announced on 21 September 2021, Alliance stated that its 2021 interim dividend payment of 0.563p per share (the "Interim Dividend") would be paid on 7 January 2022 to shareholders on the register on 24 December 2021.

Alliance would now like to update the market that it has brought forward the record date for the Interim Dividend to 17 December 2021, with the payment date remaining as 7 January 2022 as previously announced.

For further information:

Alliance Pharma plc	+ 44 (0)1249 466966
Peter Butterfield, Chief Executive Officer
Andrew Franklin, Chief Financial Officer
www.alliancepharma.co.uk
Buchanan	+ 44 (0)20 7466 5000
Mark Court / Sophie Wills / Hannah Ratcliff
Numis Securities Limited	+ 44 (0)20 7260 1000
Nominated Adviser: Freddie Barnfield / Duncan Monteith
Corporate Broking: James Black

Investec Bank plc	+ 44 (0) 20 7597 5970
Corporate Finance: Daniel Adams
Corporate Broking: Patrick Robb

About Alliance

Alliance Pharma plc (AIM: APH) is an international healthcare group. Our purpose is to improve the lives of consumers and patients through making available a range of clinically valuable healthcare products.

Our core focus is on the marketing of Consumer Healthcare brands, complemented by a smaller Prescription Medicines business. In total, we hold marketing rights to around 80 brands, with revenues generated from a mix of direct, distributor and e-commerce sales.

Headquartered in the UK, the Group employs around 250 people based in locations across Europe, North America, and the Asia Pacific region. By outsourcing our manufacturing and logistics operations, we remain asset-light and focused on maximising the value of our brands.

For more information on Alliance, please visit our website: www.alliancepharmaceuticals.com

 

END

 

 

DIVBLBDBSXGDGBC